Literature DB >> 29084045

Brief Report: Declining Baseline Viremia and Escalating Discordant HIV-1 Confirmatory Results Within South Africa's Early Infant Diagnosis Program, 2010-2016.

Ahmad Haeri Mazanderani1,2, Faith Moyo1,3, Tendesayi Kufa1,4, Gayle G Sherman1,3,5.   

Abstract

OBJECTIVE: To describe baseline HIV-1 RNA viral load (VL) trends within South Africa's Early Infant Diagnosis program 2010-2016, with reference to prevention of mother-to-child transmission guidelines.
METHODS: HIV-1 total nucleic acid polymerase chain reaction (TNA PCR) and RNA VL data from 2010 to 2016 were extracted from the South African National Health Laboratory Service's central data repository. Infants with a positive TNA PCR and subsequent baseline RNA VL taken at age <7 months were included. Descriptive statistics were performed for quantified and lower-than-quantification limit (LQL) results per annum and age in months. Trend analyses were performed using log likelihood ratio tests. Multivariable linear regression was used to model the relationship between RNA VL and predictor variables, whereas logistic regression was used to identify predictors associated with LQL RNA VL results.
RESULTS: Among 13,606 infants with a positive HIV-1 TNA PCR linked to a baseline RNA VL, median age of first PCR was 57 days and VL was 98 days. Thirteen thousand one hundred ninety-five (97.0%) infants had a quantified VL and 411 (3.0%) had an LQL result. A significant decline in median VL was observed between 2010 and 2016, from 6.3 log10 (interquartile range: 5.6-6.8) to 5.6 log10 (interquartile range: 4.2-6.5) RNA copies per milliliter, after controlling for age (P < 0.001), with younger age associated with lower VL (P < 0.001). The proportion of infants with a baseline VL <4 Log10 RNA copies per milliliter increased from 5.4% to 21.8%. Subsequent to prevention of mother-to-child transmission Option B implementation in 2013, the proportion of infants with an LQL baseline VL increased from 1.5% to 6.1% (P < 0.001).
CONCLUSIONS: Between 2010 and 2016, a significant decline in baseline viremia within South Africa's Early Infant Diagnosis program was observed, with loss of detectability among some HIV-infected infants.

Entities:  

Mesh:

Year:  2018        PMID: 29084045     DOI: 10.1097/QAI.0000000000001581

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  13 in total

1.  12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort study.

Authors:  Karl-Günter Technau; Renate Strehlau; Faeezah Patel; Stephanie Shiau; Megan Burke; Martie Conradie; Gillian Sorour; Gayle G Sherman; Ashraf Coovadia; Pamela M Murnane; Elaine J Abrams; Louise Kuhn
Journal:  Lancet HIV       Date:  2018-11-08       Impact factor: 12.767

2.  Clinical Consequences of Using an Indeterminate Range for Early Infant Diagnosis of HIV: A Decision Model.

Authors:  Phillip Salvatore; Karl Johnson; Lara Vojnov; Meg Doherty; David Dowdy
Journal:  J Acquir Immune Defic Syndr       Date:  2019-11-01       Impact factor: 3.731

3.  Early infant diagnosis HIV-1 PCR cycle-threshold predicts infant viral load at birth.

Authors:  Ahmad Haeri Mazanderani; Tendesayi Kufa; Karl G Technau; Renate Strehlau; Faeezah Patel; Stephanie Shiau; Megan Burke; Louise Kuhn; Elaine J Abrams; Gayle G Sherman
Journal:  J Clin Virol       Date:  2019-03-18       Impact factor: 3.168

4.  Negative Diagnostic PCR Tests in School-Aged, HIV-Infected Children on Antiretroviral Therapy Since Early Life in Johannesburg, South Africa.

Authors:  Faeezah Patel; Cara Thurman; Afaaf Liberty; Megan Burke; Renate Strehlau; Stephanie Shiau; Ashraf Coovadia; Elaine J Abrams; Avy Violari; Louise Kuhn
Journal:  J Acquir Immune Defic Syndr       Date:  2020-04-01       Impact factor: 3.771

5.  Non-nucleoside reverse transcriptase inhibitor levels among HIV-exposed uninfected infants at the time of HIV PCR testing - findings from a tertiary healthcare facility in Pretoria, South Africa.

Authors:  Ahmad Haeri Mazanderani; Tanya Y Murray; Gayle G Sherman; Tracy Snyman; Jaya George; Theunis Avenant; Ameena E Goga; Michael S Pepper; Nicolette du Plessis
Journal:  J Int AIDS Soc       Date:  2019-06       Impact factor: 5.396

6.  Implementing an Indeterminate Range for More Accurate Early Infant Diagnosis.

Authors:  Lara Vojnov; Martina Penazzato; Gayle Sherman; Anisa Ghadrshenas; Elaine J Abrams; Meg Doherty
Journal:  J Acquir Immune Defic Syndr       Date:  2019-11-01       Impact factor: 3.731

7.  Neurodevelopment at 11 months after starting antiretroviral therapy within 3 weeks of life.

Authors:  Barbara Laughton; Shalena Naidoo; Els F M T Dobbels; Michael J Boivin; Anita Janse van Rensburg; Richard H Glashoff; Gert U van Zyl; Mariana Kruger; Mark F Cotton
Journal:  South Afr J HIV Med       Date:  2019-10-30       Impact factor: 2.744

8.  Viral load assay performs comparably to early infant diagnosis assay to diagnose infants with HIV in Mozambique: a prospective observational study.

Authors:  Adolfo Vubil; Carina Nhachigule; Osvaldo Loquiha; Bindiya Meggi; Nedio Mabunda; Timothy Bollinger; Jilian A Sacks; Ilesh Jani; Lara Vojnov
Journal:  J Int AIDS Soc       Date:  2020-01       Impact factor: 5.396

9.  Mother-to-Child HIV Transmission With In Utero Dolutegravir vs. Efavirenz in Botswana.

Authors:  Sonya Davey; Gbolahan Ajibola; Kenneth Maswabi; Maureen Sakoi; Kara Bennett; Michael D Hughes; Arielle Isaacson; Modiegi Diseko; Rebecca Zash; Oganne Batlang; Sikhulile Moyo; Shahin Lockman; Mathias Lichterfeld; Daniel R Kuritzkes; Joseph Makhema; Roger Shapiro
Journal:  J Acquir Immune Defic Syndr       Date:  2020-07-01       Impact factor: 3.771

Review 10.  Evolving complexities of infant HIV diagnosis within Prevention of Mother-to-Child Transmission programs.

Authors:  Ahmad Haeri Mazanderani; Gayle G Sherman
Journal:  F1000Res       Date:  2019-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.